Institutional Ownership
Aim Immunotech Inc
CUSIP 00901B303COM NEWAIMQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
16
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 29.9K | $17.5K |
| 2 | Xtx Topco Ltd | 20.6K | $12.0K |
| 3 | Jane Street Group, LLC | 20.0K | $11.7K |
| 4 | Tower Research Capital LLC (Trc) | 4.7K | $2.7K |
| 5 | Morgan Stanley | 864 | $505 |
| 6 | Community Bank, N.A. | 132 | $76 |
| 7 | Virtu Financial LLC | 50.9K | $30 |
| 8 | Harbour Investments, Inc. | 32 | $19 |
| 9 | Creative Financial Designs Inc /Adv | 30 | $18 |
| 10 | Hrt Financial LP | 26.0K | $15 |